FASEB J. Avanti Polar Lipids
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.09-131920.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Buy
Right arrow All Versions of this Article:
fj.09-131920v1
23/11/3780    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Trotard, M.
Right arrow Articles by Le Seyec, J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trotard, M.
Right arrow Articles by Le Seyec, J.
(The FASEB Journal. 2009;23:3780-3789.)
© 2009 FASEB

Kinases required in hepatitis C virus entry and replication highlighted by small interference RNA screening

Maud Trotard*,{dagger}, Charlotte Lepère-Douard*,{dagger}, Morgane Régeard{dagger}, Claire Piquet-Pellorce*, Dimitri Lavillette{ddagger},§,||, François-Loic Cosset{ddagger},§,||, Philippe Gripon*,{dagger} and Jacques Le Seyec*,{dagger},1

* Equipe Associée SERAIC no. 4427, Université de Rennes 1, Rennes, IFR 140, France;

{dagger} INSERM U522, Rennes, France;

{ddagger} Université de Lyon, UCB-Lyon1, IFR 128, Lyon, France;

§ INSERM U758, Lyon, France; and

|| Ecole Normale Supérieure de Lyon, Lyon, France

1 Correspondence: EA SERAIC no. 4427, Université de Rennes 1, Faculté de Pharmacie, Ave. du Professeur Léon Bernard, 35043 Rennes Cedex, France. E-mail: jacques.leseyec{at}univ-rennes1.fr

The entry pathway of the hepatitis C virus (HCV), a major human pathogen, into the cell is incompletely defined. To better characterize this viral life cycle stage, we screened a small interfering RNA library dedicated to the membrane trafficking and remodeling with the infection model of Huh-7.5.1 cells by HCV pseudoparticles (HCVpp). Results showed that the down-regulation of different factors implied in clathrin-mediated endocytosis (CME) inhibits HCVpp cell infection. In addition, knockdown of the phosphatidylinositol 4-kinase type III-{alpha} (PI4KIII{alpha}) prevented infection by HCVpp or by cell-culture grown JFH-1-based HCV. Moreover, the replication activity of an HCV replicon was also affected by the PI4KIII{alpha} knockdown. Additional investigations on the different members of the PI4K family revealed that the presence of PI4KIIIβ in the host cells influenced their susceptibility to HCVpp infection and their capacity to sustain the HCV replication. The PI4KIII involvement during the HCV life cycle seemed to occur by other ways than the control of the CME or of the membranous expression of HCV receptors. Finally, our library screening completed data on the CME-dependant entry route of HCV and identified 2 kinases, PI4KIII{alpha} and β, as relevant potential therapeutic targets.—Trotard, M., Lepère-Douard, C., Régeard, M., Piquet-Pellorce, C., Lavillette, D., Cosset, F.-L., Gripon, P., Le Seyec, J. Kinases required in hepatitis C virus entry and replication highlighted by small interference RNA screening.


Key Words: hepacivirus • virus internalization • endocytosis • replicon • 1-phosphatidylinositol 4-kinase







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by The Federation of American Societies for Experimental Biology.